PRO-DEX, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
PRO-DEX, INC. (PDEX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $1.82 per share for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2023-05-04
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2016-09-30 was $1.79.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2013-09-30 was $1.80.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2012-09-30 was $0.00.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2011-09-30 was $0.00.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $1.94.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2019 was $2.14.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2017 was $2.07, a 3.27% decline from fiscal 2016.
- PRO-DEX, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $2.14, a 14.44% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2023-03-31 | $1.82 10-Q · filed 2023-05-04 | ||||
| 2022-12-31 | $1.82 10-Q · filed 2023-02-02 | ||||
| 2022-03-31 | $1.80 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | $1.80 10-Q · filed 2023-02-02 | ||||
| 2021-06-30 | $1.94 10-K · filed 2021-09-09 | ||||
| 2021-03-31 | $1.94 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $1.94 10-Q · filed 2022-02-03 | ||||
| 2019-06-30 | $2.14 10-K · filed 2020-09-10 | ||||
| 2019-03-31 | $2.14 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $2.14 10-Q · filed 2020-02-06 | ||||
| 2017-06-30 | $2.07 10-K · filed 2018-09-13 | ||||
| 2017-03-31 | $1.82 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $1.82 10-Q · filed 2018-02-08 | ||||
| 2016-09-30 | $1.79 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $2.14 10-K · filed 2017-09-14 | -$2.14 10-K · filed 2016-09-15 | |||
| 2016-03-31 | $2.14 10-Q · filed 2017-05-11 | ||||
| 2015-12-31 | $2.14 10-Q · filed 2017-02-09 | ||||
| 2015-06-30 | $1.87 10-K · filed 2016-09-15 | ||||
| 2015-03-31 | $1.87 10-Q · filed 2016-05-12 | ||||
| 2014-06-30 | $2.33 10-K · filed 2015-09-17 | ||||
| 2014-03-31 | $1.96 10-Q · filed 2015-05-14 | ||||
| 2013-12-31 | $1.80 10-Q · filed 2015-02-10 | ||||
| 2013-09-30 | $1.80 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $1.53 10-K · filed 2014-09-18 | ||||
| 2013-03-31 | $1.50 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $1.50 10-Q · filed 2014-02-06 | ||||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | ||||
| 2012-06-30 | $1.96 10-K · filed 2013-09-27 | ||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | $1.27 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |